Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ICCC Immucell Corp
- Stocks
- Healthcare
- NASDAQ: ICCC
Price (delayed)
$6.75
Market cap
$61M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.05
Enterprise value
$71.06M
ImmuCell Corporation's purpose is to create scientifically proven and practical products that improve the health and productivity of dairy and beef cattle. ImmuCell manufactures and markets First Defense®, providing Immediate
Highlights
ICCC's quick ratio has surged by 140% year-on-year and by 20% since the previous quarter
The net income has surged by 93% year-on-year and by 87% since the previous quarter
Key stats
What are the main financial stats of ICCC
Market
Valuations
Earnings
Shares outstanding
9.04M
Market cap
$61M
Enterprise value
$71.06M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.09
Price to sales (P/S)
2.22
EV/EBIT
N/A
EV/EBITDA
29.19
EV/Sales
2.6
Revenue
$27.3M
Gross profit
$9M
Operating income
-$222,482
Net income
-$271,778
EBIT
-$261,158
EBITDA
$2.43M
Free cash flow
$793,315
Per share
Balance sheet
Liquidity
EPS
-$0.05
EPS diluted
-$0.05
Free cash flow per share
$0.09
Book value per share
$3.23
Revenue per share
$3.04
TBVPS
$5.07
Total assets
$45.62M
Total liabilities
$16.63M
Debt
$14.66M
Equity
$28.99M
Working capital
$12.05M
Debt to equity
0.51
Current ratio
4.12
Quick ratio
2.06
Net debt/EBITDA
4.13
Margins
Efficiency
Dividend
EBITDA margin
8.9%
Gross margin
33%
Net margin
-1%
Operating margin
-0.8%
Return on assets
-0.6%
Return on equity
-1%
Return on invested capital
-0.5%
Return on capital employed
-0.6%
Return on sales
-1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ICCC stock price
How has the Immucell stock price performed over time
Intraday
-0.59%
1 week
-11.18%
1 month
8%
1 year
54.82%
YTD
31.07%
QTD
40.92%
Financial performance
How have Immucell's revenue and profit performed over time
Revenue
$27.3M
Gross profit
$9M
Operating income
-$222,482
Net income
-$271,778
Gross margin
33%
Net margin
-1%
The operating margin has surged by 96% year-on-year and by 87% since the previous quarter
Immucell's net margin has soared by 95% YoY and by 88% from the previous quarter
The operating income has soared by 94% year-on-year and by 86% since the previous quarter
The net income has surged by 93% year-on-year and by 87% since the previous quarter
Price vs fundamentals
How does ICCC's price correlate with its fundamentals
Growth
What is Immucell's growth rate over time
Valuation
What is Immucell stock price valuation
P/E
N/A
P/B
2.09
P/S
2.22
EV/EBIT
N/A
EV/EBITDA
29.19
EV/Sales
2.6
ICCC's EPS has surged by 90% year-on-year and by 81% since the previous quarter
The stock's P/B is 39% more than its last 4 quarters average of 1.5 and 23% more than its 5-year quarterly average of 1.7
The company's equity rose by 18% YoY and by 5% QoQ
The stock's P/S is 48% more than its last 4 quarters average of 1.5 but 18% less than its 5-year quarterly average of 2.7
Immucell's revenue has increased by 28% YoY and by 3.1% QoQ
Efficiency
How efficient is Immucell business performance
ICCC's return on sales has surged by 95% year-on-year and by 88% since the previous quarter
ICCC's ROIC has soared by 93% year-on-year and by 88% since the previous quarter
The company's return on equity has surged by 93% YoY and by 88% QoQ
The ROA has soared by 93% year-on-year and by 88% since the previous quarter
Dividends
What is ICCC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ICCC.
Financial health
How did Immucell financials performed over time
ICCC's total assets is 174% higher than its total liabilities
ICCC's quick ratio has surged by 140% year-on-year and by 20% since the previous quarter
Immucell's current ratio has soared by 52% YoY and by 21% from the previous quarter
Immucell's debt is 49% less than its equity
The company's debt to equity fell by 23% YoY and by 7% QoQ
The company's equity rose by 18% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.